Altimmune Inc (ALT)
7.51
+0.49
(+6.98%)
USD |
NASDAQ |
May 31, 16:00
7.48
-0.03
(-0.40%)
After-Hours: 20:00
Altimmune 1 Year Total Returns (Daily): 85.89% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 31, 2024 | 85.89% |
| May 30, 2024 | 75.50% |
| May 29, 2024 | 67.48% |
| May 28, 2024 | 70.42% |
| May 24, 2024 | 70.86% |
| May 23, 2024 | 66.82% |
| May 22, 2024 | 76.12% |
| May 21, 2024 | 71.49% |
| May 20, 2024 | 79.06% |
| May 17, 2024 | 74.13% |
| May 16, 2024 | 91.40% |
| May 15, 2024 | 82.89% |
| May 14, 2024 | 53.63% |
| May 13, 2024 | 44.79% |
| May 10, 2024 | 44.98% |
| May 09, 2024 | 56.28% |
| May 08, 2024 | 45.53% |
| May 07, 2024 | 47.17% |
| May 06, 2024 | 48.99% |
| May 03, 2024 | 46.59% |
| May 02, 2024 | 51.69% |
| May 01, 2024 | 43.70% |
| April 30, 2024 | 29.70% |
| April 29, 2024 | 26.63% |
| April 26, 2024 | 39.08% |
| Date | Value |
|---|---|
| April 25, 2024 | 37.67% |
| April 24, 2024 | 28.26% |
| April 23, 2024 | 30.74% |
| April 22, 2024 | 29.02% |
| April 19, 2024 | 15.75% |
| April 18, 2024 | 20.88% |
| April 17, 2024 | 29.17% |
| April 16, 2024 | 57.32% |
| April 15, 2024 | 57.95% |
| April 12, 2024 | 94.40% |
| April 11, 2024 | 102.9% |
| April 10, 2024 | 98.27% |
| April 09, 2024 | 109.5% |
| April 08, 2024 | 114.7% |
| April 05, 2024 | 134.9% |
| April 04, 2024 | 116.0% |
| April 03, 2024 | 110.2% |
| April 02, 2024 | 121.7% |
| April 01, 2024 | 142.4% |
| March 28, 2024 | 130.3% |
| March 27, 2024 | 84.44% |
| March 26, 2024 | 100.2% |
| March 25, 2024 | 97.45% |
| March 22, 2024 | 116.2% |
| March 21, 2024 | 84.04% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.02%
Minimum
Sep 23 2019
1.32K%
Maximum
Jul 20 2020
98.69%
Average
-8.03%
Median
Jun 30 2021
1 Year Total Returns (Daily) Benchmarks
| Eli Lilly and Co | 92.42% |
| Amgen Inc | 42.95% |
| Pfizer Inc | -20.36% |
| Viking Therapeutics Inc | 183.7% |
| GlycoMimetics Inc | -85.40% |